Hepatocellular carcinoma - History, current status and perspectives

Digestive and Liver Disease

Volumn 34, Issue 9, 2002, Pages 613-616

  Okuda, K ^a,b  

^a CHIBA UNIVERSITY   (Japan)

^b CHIBA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AFLATOXIN; ALCOHOL; ALPHA FETOPROTEIN; CARCINOGEN; CORE PROTEIN; CYANOGINOSIN; DECARBOXYPROTHROMBIN; EOSIN; HEMATOXYLIN; INTERFERON;

ARTICLE; ARTIFICIAL EMBOLISM; CANCER CELL; CANCER CLASSIFICATION; CANCER INCIDENCE; CANCER SCREENING; CANCER SURGERY; CANCER SURVIVAL; CELL DIFFERENTIATION; CHROMOSOME ANALYSIS; COLON CANCER; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DOPPLER ECHOGRAPHY; ENVIRONMENTAL EXPOSURE; ETHNIC DIFFERENCE; GENETIC ANALYSIS; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER WEIGHT; NOMENCLATURE; NONHODGKIN LYMPHOMA; VIRUS CARCINOGENESIS; VIRUS INFECTION;

EID: 0036742247     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1590-8658(02)80200-6     Document Type: Article

References (32)

1. Eggel H, Ueber das primäre Carcinom der Leber. Beitr z path Ana z allg Path 1910;30:506-604
2. Yamagiwa K. Zum Kenntniss des primären parenchymatosen Leberkarzinoms ("Hepatoma"). Virchows Arch Path Anat 1911;203:75-131.
3. Berman C. Primary carcinoma of the Liver. London: Higginson Lewis; 1951.
4. Okuda K, Peters RL, Simson IW. Gross anatomical features of hepatocellular carcinoma from three disparate geographic areas. Proposal of new classification. Cancer 1984;54:2165-73.
5. Steiner PE. Cancer of the liver and cirrhosis in trans-Saharan Africa and the United States of America. Cancer 1960;13:1085-166.
6. Nakashima T, Okuda K, Kojiro M, Jimi A, Yamaguchi R, Sakamoto K, et al. Pathology of hepatocellular carcinoma in Japan. 232 consecutive cases of autopsies in ten years. Cancer 1983;51:863-77.
7. Okuda K. Natural history of hepatocellular carcinoma including fibrolamellar and hepato-cholangiocarcinoma variants. J Gastroenterol Hepatol 2002; 17: (in press).
8. Okuda K, Fujimori I, Hanai A, Urano Y. Changing incidence of hepatocellular carcinoma in Japan. Cancer Res 1987;47:4967-72.
9. Colombo M, de Franchis R, Ninno ED, Sangiovanni A, De Fazio C, Tommasini M, et al. Hepatocellular carcinoma in Italian patients with cirrhosis. N Engl J Med 1991;325:675-80.
10. Okuda K, Nakanuma Y, Miyazaki M. Cholagiocarcinoma. Recent progress. J Gastroenterol Hepatol 2002;17:1049-63.
11. Koike K. Role of hepatitis viruses in multistep hepatocarcinogenesis. Digest Liver Dis 2001;33:2-6.
12. Okuda K, The Liver Cancer Study Group of Japan. Primary liver cancer in Japan. Cancer 1980;45:2663-9.
13. Okuda K. Early recognition of hepatocellular carcinoma. Hepatology 1986;6:729-38.
14. Okuda H, Nakashima T, Takatsu K, Saito A, Hayashi N, Watanabe K, et al. Measurement of serum levels of des-α-carboxy prothrombin in patients by a revised enzyme immunoassay kit with increased sensitivity. Cancer 1999;85:812-8.
15. Shiraki K, Takase K, Tameda Y, Tameda Y, Harada M, Kosaka Y, et al. A clinical study of lectin-reactive alpha-fetoprotein as an early indicator of hepatocellular carcinoma in the follow-up of cirrhotic patients. Hepatology 1995;22:802-7.
16. Arakawa M, Kage M, Sugihara S, Nakashima T, Suenaga M, Okuda K. Emergence of malignant lesions within an adenomatous hyperplastic nodule in a cirrhotic liver. Observations in five cases. Gastroenterology 1986;91:198-208.
17. Fearon ER. Molecular genetics of colorectal cancer. Ann NY Acad Sci 1995;768:101-10.
18. Kudo M. Imaging diagnosis of hepatocellular carcinoma and premalignant/borderline lesions. Semin Liver Dis 1999;19:297-307.
19. Sogiura N, Takara K, Ohto M, Okuda K, Hirooka N. Treatment of small hepatocellular carcinoma with ultrasound guide ethanol injection. Acta Hepatol Jpn 1983;24:920.
20. Rossi S, Fornari F, Buscarrini L. Percutaneous ultrasound-guided radiofrequency electrocauthery for the treatment of small hepatocellular carcinoma. J Intervent Radiol 1993;8:97-103.
21. Mazzaferro V, Regallia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al. Liver transplantation for the treatment of small hepatocellular carcinoma in patients with cirrhosis. N Engl J Med 1996;334:693-9.
22. Tanaka A, Tanaka K, Kaihara S, Ueda M, Uemoto S, Kiuchi T, et al. Liver transplantation for hepatocellular carcinoma. Nippon Rinsho 2001;6(Suppl):705-16.
23. Patzer JF. Advances in bioartificial liver assist devices. Ann NY Acad Sci 2001;944:320-33.
24. Chang M, Chen CJ, Lai MS, Hsu HM, Wu TC, Kong MS, et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. N Engl J Med 1997;336:1855-9.
25. Ikeda K, Saito S, Koida I, Arase Y, Tsubota A, Chayama K, et al. A multivariate analysis of risk factors for hepatocellular carcinoma: a prospective observation of 795 patients with viral and alcoholic cirrhosis. Hepatology 1993;18:47-53.
26. Seeff LB, Hollinger B, Alter H, Wright GC, Cain CMB, Buskell ZJ, et al. Long-term mortality and morbidity of transfusion-associated non-A, non-B, and type C hepatitis: a national heart, lung and blood institute collaborative study. Hepatology 2001;33:455-63.
27. Barrett S, Goh J, Coughlan B, Ryan E, Stewart S, Cockram A, et al. The natural course of hepatitis C virus infection after 22 years in a unique homogeneous cohort spontaneous viral clearance and chronic HCV infection. Gut 2001;49:423-30.
28. Wiese N, Berr WM, Porst LM, Oessen U for the East German Hepatitis C Study Group. Low frequency of cirrhosis in a hepatitis C (genotype 1b) single-source outbreak in Germany: a 20-year multicenter study. Hepatology 2000;32:91-6.
29. Yu, SZ. Primary prevention of hepatocellular carcinoma. J Gastroenterol Hepatol 1995;10:673-82.
30. Nishiguchi S, Kuroki T, Nakatani S, Morimoto H, Takeda T, Nakajima S, et al. Randomized trial of effects of interferon-α on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis. Lancet 1995;346:1051-5.
31. Yoshida H, Shiratori Y, Moriyama M, Arakawa Y, Ide T, Sata M, et al. Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhosis and noncirrhotic patients with chronic hepatitis C in Japan. Ann Intern Med 1999;131:174-81.
32. Muto Y, Moriwaki H, Ninomiya M, Adachi S, Saito A, Takasaki KT, et al. Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. Hepatoma Prevention Study Group. N Engl J Med 1996;344:1561-7.